Evidence map›Paper›PMID 31099339›Full record

ArticleJournal of medical Internet research2019

Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine.

Xiaofang Wang, Yan Zhang, Shiying Hao, Le Zheng, Jiayu Liao, Chengyin Ye, Minjie Xia, Oliver Wang, Modi Liu, Ching Ho Weng and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 3 countries.

Xiaofang Wang *Shandong Provincial Key Laboratory of Network Based Intelligent Computing, University of Jinan, Jinan, China.ORCID 0000-0003-2448-9456
Yan Zhang *Department of Oncology, The First Hospital of Shijiazhuang, Shijiazhuang, China.ORCID 0000-0002-2198-5393
Shiying Hao *Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0002-7527-2460
Le ZhengDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0003-4744-367X
Jiayu LiaoDepartment of Bioengineering, University of California, Riverside, CA, United States.ORCID 0000-0002-2624-5781
Chengyin YeDepartment of Health Management, Hangzhou Normal University, Hangzhou, China.ORCID 0000-0001-8384-1857
Minjie XiaHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0002-0367-1729
Oliver WangHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0001-6240-1342
Modi LiuHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0002-8066-3351
Ching Ho WengDepartment of Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0001-8403-3501
Son Q DuongLucile Packard Children's Hospital, Palo Alto, CA, United States.ORCID 0000-0001-7657-9520
Bo JinHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0001-9268-7134
Shaun T AlfredsHealthInfoNet, Portland, ME, United States.ORCID 0000-0003-1752-4823
Frank StearnsHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0003-2049-9163
Laura KanovHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0003-0469-6589
Karl G SylvesterDepartment of Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0002-8559-0155
Eric WidenHealthcare Business Intelligence Solutions Inc, Palo Alto, CA, United States.ORCID 0000-0002-8999-4659
Doff B McElhinneyDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0001-7242-0934
Xuefeng B Ling *Department of Surgery, Stanford University, Stanford, CA, United States.ORCID 0000-0002-5386-3884
Siemens Healthineers (Germany) · DELucile Packard Children's Hospital · USStanford University · USFirst Hospital of Shijiazhuang · CNHangzhou Normal University · CNLifenet Health · USUniversity of California, Riverside · USUniversity of Jinan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is the leading cause of cancer death worldwide. Early detection of individuals at risk of lung cancer is critical to reduce the mortality rate.

objectiveThe aim of this study was to develop and validate a prospective risk prediction model to identify patients at risk of new incident lung cancer within the next 1 year in the general population.

methodsData from individual patient electronic health records (EHRs) were extracted from the Maine Health Information Exchange network. The study population consisted of patients with at least one EHR between April 1, 2016, and March 31, 2018, who had no history of lung cancer. A retrospective cohort (N=873,598) and a prospective cohort (N=836,659) were formed for model construction and validation. An Extreme Gradient Boosting (XGBoost) algorithm was adopted to build the model. It assigned a score to each individual to quantify the probability of a new incident lung cancer diagnosis from October 1, 2016, to September 31, 2017. The model was trained with the clinical profile in the retrospective cohort from the preceding 6 months and validated with the prospective cohort to predict the risk of incident lung cancer from April 1, 2017, to March 31, 2018.

resultsThe model had an area under the curve (AUC) of 0.881 (95% CI 0.873-0.889) in the prospective cohort. Two thresholds of 0.0045 and 0.01 were applied to the predictive scores to stratify the population into low-, medium-, and high-risk categories. The incidence of lung cancer in the high-risk category (579/53,922, 1.07%) was 7.7 times higher than that in the overall cohort (1167/836,659, 0.14%). Age, a history of pulmonary diseases and other chronic diseases, medications for mental disorders, and social disparities were found to be associated with new incident lung cancer.

conclusionsWe retrospectively developed and prospectively validated an accurate risk prediction model of new incident lung cancer occurring in the next 1 year. Through statistical learning from the statewide EHR data in the preceding 6 months, our model was able to identify statewide high-risk patients, which will benefit the population health through establishment of preventive interventions or more intensive surveillance.

Indexed as

Cohort StudiesEarly Detection of CancerElectronic Health RecordsFemaleHumansIncidenceLung NeoplasmsMaineMaleProspective StudiesRetrospective Studieselectronic health recordslung cancerprospective studyrisk prediction model

Identifiers

PMID31099339
PMCPMC6542253
OpenAlexW2975026923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.